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Abstract
Introduction Improving health-related quality of life
(HRQoL) is increasingly recognized as an essential part of
patient care outcome. Little is known about the effect of
laparoscopic antireflux surgery (LARS) on the HRQoL in
the pediatric patients. The aims of this study were to
evaluate the effect of LARS on HRQoL in children with
gastroesophageal reflux disease (GERD) and to identify
predictors that influence HRQoL outcome after LARS.
Methods Between 2011 and 2013, 25 patients with ther-
apy-resistant GERD [median age 6 (2–18) years] were
included prospectively. Caregivers and children with nor-
mal neurodevelopment ([4 years) were asked to fill out the
validated PedsQL 4.0 Generic Core Scales before and
3–4 months after LARS.
Results The PedsQL was completed by all caregivers
(n = 25) and 12 children. HRQoL total score improved
significantly after LARS, both from a parental (p = 0.009)
and child’s perspective (p = 0.018). The psychosocial
health summary and physical health summary scores also
improved significantly after LARS. HRQoL before and
after LARS was significantly lower in children with
impaired neurodevelopment (p\ 0.001). However, neu-
rodevelopment did not influence the effect of LARS on
HRQoL. The only significant predictor for improvement in
HRQoL after LARS was age at the time of operation
(p = 0.001).
Conclusions HRQoL significantly improves after LARS.
Although children with impaired neurodevelopment had
lower overall HRQoL, neurodevelopment by itself does not
predict inferior improvement in HRQoL after LARS. Older
children have amore favorableHRQoLoutcome after LARS
compared to younger children. This may suggest caution
when considering LARS in younger GERD patients.
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Laparoscopic antireflux surgery (LARS) is an established
treatment option performed in pediatric patients with sev-
ere gastroesophageal reflux disease (GERD) resistant to
medical treatment [1, 2]. LARS primarily aims to decrease
(acid) reflux events and to reduce reflux symptoms. How-
ever, as shown in earlier studies the effect on reflux
symptoms does not always correlate to more objective
assessments of success of therapy [3, 4]. Furthermore,
comorbidities (e.g., impaired neurodevelopment) and
complications, such as dysphagia and gas-bloat syndrome
[5], may also affect success of therapy.
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and Other Interventional Techniques 
To better assess the impact of pediatric diseases and
treatments from the perspective of the pediatric patient and
their caregivers health-related quality of life (HRQoL),
assessment has been increasingly recognized as an essen-
tial part of patient care outcome [6]. Effects of LARS on
HRQoL have been mainly investigated in adult population.
These studies almost all showed that HRQoL improves
after LARS [7–9]. In the pediatric population, only few
studies have focused on this outcome parameter [10–12].
HRQoL in these studies improves; however, none of these
studies have used pediatric validated questionnaires. In two
studies [10, 11], a questionnaire designed for adults had
been modified for pediatric use and one study had only
used parental proxy report to score HRQoL [12]. Further-
more, none of these studies could identify determinants that
influence HRQoL outcome after LARS. The Pediatric
Quality of Life Inventory (http://www.pedsql.org.) 4.0
Generic Core Scales (PedsQL) is a reliable and valid tool
(also for the Dutch language) for parental proxy report and
parallel child’s self-report on HRQoL. It has been used to
assess HRQoL in children with numerous acute and
chronic health conditions, as well as in healthy populations
[6, 13–17]. The aim of this study was to evaluate the effect
of LARS on HRQoL using the PedsQL and to identify
predictors that may influence HRQoL outcome after
LARS.
Patients and methods
We performed a prospective multicenter study in three
University Medical Centers in the Netherlands performing
laparoscopic fundoplication in children (Wilhelmina chil-
dren’s Hospital, University Medical Center Utrecht
(UMCU): Sophia children’s Hospital, Erasmus University
Medical Center (EMC) and Maastricht University Medical
Center (MUMC). From July 2011 until December 2013, we
prospectively included all pediatric patients diagnosed with
PPI-therapy-resistant GERD. Patients that had undergone
previous esophageal or gastric surgery (except previous
gastrostomy placement) and those who had structural
abnormalities other than an esophageal hiatal hernia were
excluded.
Patients
In total, 25 children were included. Mean age of the
included patients was six (range 2–18) years at the
time of fundoplication (Table 1). Impaired neurode-
velopment was present in 20% of patients (5/25
patients). Causes of impaired neurodevelopment are
shown in Table 2.
Surgical procedures
All laparoscopic fundoplications were performed by
experienced pediatric surgeons in pediatric laparoscopic
surgery. In the UMCU the anterior, partial fundoplication
according to Thal [18] was used to perform fundoplication.
In the other two UMC’s (EMC and MUMC) the posterior,
total fundoplication according to Nissen [19] was per-
formed. Before fundoplication, the distal esophagus was
fully mobilized; the distal 3 cm of the esophagus was
repositioned back into the abdomen. Both vagal nerves
were identified, and after dissection of both crura the hiatus
was closed routinely (UMCU and EMC). Thereafter, the
fundoplication was constructed. The Thal fundoplication
was performed by plicating the fundus of the stomach over
270 against the distal anterior intra-abdominal part of the
esophagus and the diaphragmatic crus [3, 18]. A floppy
Nissen was constructed with one of the sutures of the 360
posterior wrap incorporated in the esophageal wall [19].
Clinical assessment
Before and 3 months after laparoscopic fundoplication,
clinical assessment was performed using the PedsQL 4.0
Generic Core Scale for HRQoL, a reflux-specific symptom
questionnaire, 24-h multichannel intraluminal impedance-
pH monitoring (MII-pH monitoring) and an 13C-labeled
Na-octanoate breath test. Surgical re-interventions, type
and indication for re-intervention, endoscopic procedures,
complications, and comorbidities were registered in a
prospective database.
1. Health-related Quality of Life—caregivers and chil-
dren with normal neurodevelopment ([4 years) were
asked to fill out the 23-items PedsQL 4.0 Generic Core
Scales [1, 14, 17, 19–21]. The scales are available for
parental proxy report, subdivided in four age-adjusted
questionnaires (ages: 2–4; 5–7; 8–12; and
13–18 years) and as a parallel child’s self-report (ages:
5–7; 8–12; and 13–18 years). The PedsQL 4.0 Generic
Core Scales comprises four domains: physical
Table 1 Baseline characteristics
Median (IQR)
Age at time of operation (years) 6.0 (3.0–11.0)
Duration of hospital admission (days) 3.0 (2.0–4.5)
n (%)
Male gender 12 (48.0%)
Neurological normal development 20 (80.0%)
Gastrostomy preoperatively in situ 4 (16.0%)
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functioning (8 items), emotional functioning (5 items),
social functioning (5 items), and school functioning (5
items). With the four domains, the physical health
summary score, the psychosocial summary score and the
total score are calculated. The physical health summary
score is reflected by the physical functioning scale. The
psychosocial health summary score is reflected by the
mean of the other three domains (emotional, social and
school functioning). Scale scores per domain were
computed as the sum of the items divided by the number
of items answered. Thereafter, items were reverse-
scored and transformed to a 0–100 scale. Higher scale
scores indicate better HRQoL.
2. Reflux-specific questionnaire—patients and/or their
parents were asked to fill out the Gastroesophageal
Reflux Symptom Questionnaire [22].
3. Ambulatory 24-h MII-pH monitoring—MII-pH mon-
itoring was performed using an age-adjusted combined
impedance-pH catheter (Unisensor AG, Attikon,
Switzerland). Pathological acid exposure was defined
as total acid exposure time C6, C9% in upright, and
C3% in the supine body position [23, 24]. The
symptom index (SI) and the symptom association
probability (SAP) was calculated when the patients
experienced symptoms during measurement [25, 26].
4. Gastric emptying breath test—to assess gastric emp-
tying time, we used a 13C-labeled Na-octanoate breath
test [27]. Gastric emptying half time is defined as the
time when the first half of the 13C-labeled substrate
has been metabolized, that is, when the cumulative
excretion of 13C in the breath is half the ingested
amount. Gastric emptying percentiles were calculated
according to the reference values obtained by van den
Driessche et al. [28].
Ethical approval and trial registration
This study was registered at the start of the study in the
Dutch national trial registry (www.trailregister.nl; Identi-
fier: 2934). Ethical approval for this prospective multi-
center study was obtained from the University Medical
Center Utrecht Ethics Committee, and local approval was
obtained by the remaining two participating centers. Prior
to any trial-related study procedure, informed consent from
the patients’ parents and children (C12 years) was
obtained.
Statistical analysis
Continuous variables, when symmetric, were expressed as
mean ± standard error. Skewed variables were expressed
as median with interquartile ranges (IQR). For statistical
analysis, we used the paired sample t test or the Wilcoxon
signed-ranks test. The McNemar–Bowker test was used to
compare groups in case of nominal outcome measures. To
assess the relationship between HRQoL and age at the time
of operation, impaired neurodevelopment, reflux symp-
toms, acid exposure and gastric emptying, we used a linear
mixed model with a random intercept per patient. A mixed
model allowed us to analyze preoperative and postopera-
tive measurements simultaneously, while taking into
account correlation of measurements from the same sub-
jects. Backwards selection was performed using the AIC. A
linear regression analysis was performed to identify
determinants influencing HRQoL and the effect of LARS
on HRQoL. Determinant of interest included: age at the
time of operation, impaired neurodevelopment, reflux
symptoms, preoperative acid exposure time and preopera-
tive gastric emptying rate. Differences with a p\ 0.05
were considered statistically significant. All analyses were
performed using IBM 22.0.0 SPSS statistical package
(IBM, Armonk, NY).
Results
In total, 18 Thal and 7 Nissen fundoplications were per-
formed. In all patients, fundoplication was completed by
laparoscopy. Perioperative complications were not
observed. One patient with retching due to impaired neu-
rodevelopment developed severe recurrent reflux caused by
hiatal herniation that required re-fundoplication. In six
children, temporary nasogastric tube feedings were
required to obtain sufficient caloric intake. This was caused
by transient dysphagia (dysphagia dissolved within
3–4 months after LARS; n = 4), persistent dysphagia
([3–4 months after LARS; n = 1) or refusal of oral
feedings (n = 1).
Health-related quality of life
The PedsQL was completed by all caregivers both before
and after LARS for all included patients (n = 25). The
HRQoL total score improved significantly after LARS
from 69.8 (57.2–80.1) to 82.0 (69.3–89.2; p = 0.009;
Fig. 1a). Twelve children were able to fill out the parallel
Table 2 Neurological impairment (n = 5)
Charge syndrome
Mitochondrial complex II deficiency
Post-hypoxic encephalopathy
Congenital rubella infection
Neurologically impairment of unknown origin with autistic
behavior
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self-report, and their total score also improved significantly
from 72.6 (7.4–82.3) to 84.6 (78.1–91.3; p = 0.018;
Fig. 1).
Furthermore, the psychosocial [54.2 (69.7–77.5) to 82.5
(72.9–89.6); p\ 0.0001] and the physical health summary
[75.0 (59.4–89.1) to 92.2 (80.5–99.2); p\ 0.0001] also
significantly improved for both caregivers as well as chil-
dren’s self-report after LARS (Figs. 2, 3).
Patients’ self-report of overall HRQoL outcomes was
significantly higher (p = 0.037) than parental proxy report
before LARS; self-reported and proxy-reported HRQoL
scores after LARS were not different.
Reflux symptoms
Reflux symptoms significantly decreased from 16 (64%)
patients with severe reflux symptoms before LARS to one
(4%) patient after LARS (p = 0.001). Deterioration of
symptom severity or frequency was not seen in any of the
patients. Dysphagia was reported in seven (28%) patients
before and in eight (32%) patients after LARS (p = 0.887).
New-onset dysphagia was seen in three of these eight
patients after LARS (Table 3).
Gastroesophageal functional assessment tests—total
acid exposure decreased significantly from 8.5% (IQR
2.5–32.8) to 0.8% (IQR 0–21.6) after LARS (p\ 0.0001).
Median gastric emptying rate before LARS (percentile 75,
IQR 3–99) was similar to that after LARS (70, IQR 5–99,
p = 0.530).
Factors influencing HRQoL
Patients with impaired neurodevelopment (NI) had signif-
icantly lower HRQoL compared to patients with normal
neurodevelopment (NN) (estimate 23.4; p = 0.006; (95%
CI 7.2–39.5). Furthermore, reflux symptoms were also
Fig. 1 HRQoL assessment using the PedsQL—total score (pre = be-
fore LARS; post = after LARS; P = parental proxy report;
C = child’s self-report)
Fig. 2 HRQoL assessment using the PedsQ—psychosocial health
summary (pre = before LARS; post = after LARS; P = parental
proxy report; C = child’s self-report)
Fig. 3 HRQoL assessment using the PedsQL—physical health
summary (pre = before LARS; post = after LARS; P = parental
proxy report; C = child’s self-report)
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negatively associated with lower HRQoL (esti-
mate = -4.3 l; p = 0.006; 95% CI -7.5 to -1.3). Age at
the time of operation (p = 0.11), gastric emptying
(p = 0.82) and total acid exposure (p = 0.75) did not
significantly influence HRQoL.
Predictors for the effect of LARS on HRQoL
Linear regression analysis showed that an increase in age at
the time of operation was a significant predictor for
improvement in HRQoL after LARS (p = 0.001; esti-
mate = 1.6; 95% CI 0.8–2.5; Fig. 4). Although HRQoL
was significantly lower in NI children, neurodevelopment
itself did not influence the change in HRQoL (p = 0.73).
Preoperative gastric emptying rate, total acid exposure time
and reflux symptoms also did not significantly influence the
change in HRQoL (Table 4).
Discussion
This is the first study on HRQoL in children undergoing
LARS that used a validated pediatric HRQoL questionnaire
[6, 13–17]. We demonstrate that after LARS HRQoL sig-
nificantly increases and after LARS HRQoL scored were
comparable to the normal HRQoL scores measured in a
healthy population [13]. Furthermore, age at the time of
operation is a significant predictor for improvement in
HRQoL after LARS. Previous studies also showed a sig-
nificant increase in HRQoL [10–12]. In two studies
[10, 11], a questionnaire designed for adults had been
modified for pediatric use and the third study only used
parental proxy report. In contrast to these previous studies,
this is the first study in pediatric LARS using a validated
questionnaire for HRQoL. Using validated questionnaires
in the pediatric population is important as results and
questionnaires are not simply translatable for pediatric uses
because pathophysiology, and patterns and symptoms of
diseases may be different in children compared to adults
[29]. Furthermore, this is the first study using both parental
proxy reports as well as child’s self-reports.
Some authors hypothesize that children with impaired
neurodevelopment (NI) may not benefit to the same extent
from LARS as those with normal development [30–32]. In
the current study, overall HRQoL was significantly lower
in NI children. However, the neurodevelopment itself did
not influence the change in HRQoL. This indicates that
while NI children with GERD had a lower overall HRQoL,
LARS was equally effective regarding the change in
HRQoL compared to children with normal neurodevelop-
ment (NN). It is not surprising that NI children, who have
more (co-) morbidity than NN children, scored lower in
HRQoL; the PedsQL is able to distinguish between healthy
children and pediatric patients with acute or chronic health
conditions, and it is related to indicators of morbidity and
illness burden [21].
The HRQoL scores of NI children for physical, social
and school functioning were scored significantly lower
compared to NN children. Emotional function, however,
was not scored different from NN (data not shown). As NI
children have more (co-)morbidities and associated dis-
abilities they will likely score lower in physical and social
functioning. The scores in the domain school functioning
may be influenced by the possibility for caregivers or
patients to leave these questions open if they are not
applicable. If at least 50% is filled out in a specific domain,
the score over that domain can, however, still be calcu-
lated. In the domain school functioning questions regarding
attitude and performance at school were generally not filled
out, whereas questions regarding presence/absence due to
sickness or hospital visits were almost completely filled out
by the caregivers.
Before LARS, children reported a significantly higher
HRQoL than their parental proxies. This difference
remained when only the child’s self-report was compared
to the score of their parents and the scores of the parents
with children aged\5 or NI children were not taken into
account. After LARS, this difference resolved as parents
scored the HRQoL higher than children. It is not entirely
clear why this difference in HRQoL resolves after LAR.
We hypothesize that before LARS caregivers experience
more burden from GERD on their child’s HRQoL com-
pared to their children’s own perception. After LARS,
GERD resolves in almost all children and it may therefore
be possible that HRQoL assessments after LARS are
therefore comparable.
Table 3 Symptoms (n = 25)
Preoperative (n; %) 3–4 months postoperative (n; %) p value
Reflux symptoms
No symptoms 0 (0%) 17 (68%) 0.001
Mild reflux symptoms 2 (8%) 5 (20%)
Moderate reflux symptoms 7 (28%) 2 (8%)
Severe reflux symptoms 16 (64%) 1 (4%)
Dysphagia 7 (28%) 8 (32%) 0.887
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Various studies on HRQoL in children indicate that
information provided by caregivers does not always cor-
respond to what children report themselves [33, 34].
Pediatric patient self-report is considered to be the standard
for measuring HRQoL, as it is the only genuine patient-
reported outcome [35]. It can, however, be difficult to
obtain self-reports in young children and children with
impaired neurodevelopment. In these cases, a parental
proxy report may be the only way to assess HRQoL [36].
Furthermore, it has been shown that the parents’ perception
of their child’s HRQoL influences health care utilization
more than the perception of the child itself [37, 38].
Age at the time of operation was a statistically signifi-
cant predictor of improvement in HRQoL after LARS. This
means that LARS has more effect on HRQoL in older
children and may suggest caution when younger children
are referred for therapy-resistant GERD. It has been sug-
gested that recurrence of GERD and even the necessity for
redo-fundoplication are more frequently seen in young
patients. These suggestions were based on two retrospec-
tive studies both using regression analysis to identify risk
factors [39, 40]. Bearg et al. [39] showed that redo-fun-
doplication is significantly more frequent if patients are
younger or have retching. Ngerncham et al. [40] reported
that age less than 6 years was independently associated
with increased risk of recurrence of GERD. Furthermore, it
may also be possible that older children can specify their
(reflux) complaints better, allowing a more precise diag-
nosis of therapy-resistant GERD to be made. Finally, it has
been hypothesized that a young child may outgrow its
fundoplication [4].
We initially hypothesized that preoperative gastric
emptying might influence the success of LARS and thereby
the effect on HRQoL as this has been shown in adult lit-
erature [41]. In this study, however, we did not find an
effect of gastric emptying on HRQoL.
Fig. 4 Scatterplot illustrating
difference in HRQoL
comparing pre- to post-LARS
HRQoL
Table 4 Predictors for the
effect of LARS on HRQoL
Estimate p value 95% CI
Age at time of operation 1.7 0.001 0.8–2.5
Neurological development 1.8 0.73 -9.3–12.9
Preoperative reflux symptoms 2.8 0.61 -8.7–14.4
Preoperative acid exposure time (%) 0.3 0.28 -0.3–0.9
Preoperative gastric emptying -0.004 0.94 -0.1–0.1
Linear regression analysis (95% CI, 95% confidence interval)
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It is plausible that reflux symptoms and acid exposure
influence HRQoL assessment. In the current study, reflux
symptoms were negatively associated with lower HRQoL.
Remarkably, however, recurrence or persisting pathologi-
cal acid exposure did not significantly influence HRQoL. It
has been described before that reflux symptoms do not
correlate to objective measurements of GERD, which may
underscore the difficulty in symptom assessment [3, 4, 42].
One of the limitations in the current study was the limited
number of 25 patients included. It was therefore only pos-
sible to investigate 5 determinants in linear regression
assuming that we have sufficient statistical power with 5
patients per predictor. If more patients were included in this
study, we would have had more power to detect the influ-
ence of these variables, and we had been able to investigate
more potential determinants of changes in HRQoL. Sec-
ondly, this limited sample size, in addition to variations in
surgical technique and multiple institutions, results to var-
ious forms of potential bias, such as confounding or type 2
errors. Furthermore, not all patients were able to fill out the
self-report because of impaired neurodevelopment or age
and as mentioned previously not all questions could be
filled out by their caregivers, because in specific domains
the questions were not always suitable when considering
comorbidities and patient’s limitations.
In conclusion, health-related quality of life, scored by
both pediatric patients and their caregivers, significantly
improves after LARS. Although patients with impaired
neurodevelopment have lower overall HRQoL compared to
neurologically normal developed patients, neurodevelop-
ment itself is not a predictor of inferior improvement in
HRQoL after LARS. Older children have a more favorable
outcome of LARS on HRQoL compared to younger chil-
dren. This suggests that with the diagnosis of therapy-re-
sistant GERD in younger children, one should possibly be
cautious to perform LARS.
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